Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scivanta Medical Corporation was a medical technology company focused on the development and commercialization of non-invasive cardiac monitoring systems. Its flagship product, the Scivanta Cardiac Monitor (SCM), utilized advanced bioimpedance technology to provide real-time data on cardiac output, stroke volume, and other hemodynamic parameters. The company aimed to provide clinicians with a cost-effective, non-invasive alternative to pulmonary artery catheterization for managing patients with heart failure and other cardiovascular conditions. Originally founded as HumaScan, the company rebranded in 2006 to reflect its shift from cancer diagnostics to cardiology. Despite obtaining regulatory clearances and establishing a presence in the cardiac monitoring market, the company eventually faced financial difficulties and ceased active operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scivanta Medical.